SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea · Delayed Price · Currency is KRW 2,595.00
+145.00 (5.92%)
At close: Jul 27, 2026
SELVAS Healthcare Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16,918 | 3,889 | 3,152 | 5,170 | 2,813 | 2,472 |
Depreciation & Amortization | 927.28 | 934.37 | 1,048 | 1,011 | 1,099 | 1,582 |
Loss (Gain) From Sale of Assets | - | - | -13.26 | 146.44 | -3.61 | -5.08 |
Asset Writedown & Restructuring Costs | -0.57 | -0.57 | - | - | 200.8 | 709.2 |
Loss (Gain) From Sale of Investments | -16,851 | -4,671 | 1,638 | -233.99 | -13.67 | - |
Loss (Gain) on Equity Investments | 39.04 | 37.29 | 200.83 | - | - | - |
Stock-Based Compensation | - | - | 95.74 | 388.29 | 293.61 | - |
Provision & Write-off of Bad Debts | 134.97 | 1,357 | -139.93 | 1.79 | 52.04 | -77.12 |
Other Operating Activities | 1,305 | 1,708 | 62.37 | -1,125 | 265.7 | -153.35 |
Change in Accounts Receivable | 3,628 | -1,064 | -2,902 | -1,106 | -134.39 | -831.55 |
Change in Inventory | -1,087 | -913.3 | 2,327 | -1,013 | -3,075 | 114.64 |
Change in Accounts Payable | -347.83 | 143.56 | -162.15 | 93 | -548.19 | -183.49 |
Change in Other Net Operating Assets | -2,459 | -1,116 | -807.8 | 140.48 | -897.61 | -698.61 |
Operating Cash Flow | 2,207 | 304.75 | 4,500 | 3,472 | 50.81 | 2,928 |
Operating Cash Flow Growth | -54.32% | -93.23% | 29.61% | 6733.30% | -98.27% | -30.71% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1,142 | -856.8 | -716.31 | -359.64 | -352.31 | -371.2 |
Sale of Property, Plant & Equipment | - | - | 12.05 | 10.36 | 3.97 | 5.91 |
Sale (Purchase) of Intangibles | -353.7 | -244.9 | -20.58 | -9.27 | -8.33 | -4.8 |
Investment in Securities | -1,407 | - | 155.75 | -11,565 | 2,611 | -1,034 |
Other Investing Activities | 3.97 | -2,032 | -25.04 | -2,047 | -28.32 | 20.08 |
Investing Cash Flow | -2,898 | -3,134 | -594.13 | -13,971 | 2,226 | -1,384 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 1,293 | 6,590 | 1,205 | 792.45 | - |
Long-Term Debt Issued | - | - | - | - | 245 | 5,999 |
Total Debt Issued | 1,162 | 1,293 | 6,590 | 1,205 | 1,037 | 5,999 |
Short-Term Debt Repaid | - | -1,856 | -5,832 | -1,157 | - | -3,000 |
Long-Term Debt Repaid | - | -826.27 | -1,683 | -4,907 | -8,864 | -4,377 |
Total Debt Repaid | -2,570 | -2,682 | -7,515 | -6,064 | -8,864 | -7,377 |
Net Debt Issued (Repaid) | -1,407 | -1,389 | -924.82 | -4,859 | -7,827 | -1,378 |
Issuance of Common Stock | - | - | 199.92 | 20,754 | - | - |
Other Financing Activities | -7.45 | -4.97 | 37.05 | 50.47 | 0 | 0 |
Financing Cash Flow | -1,415 | -1,394 | -687.85 | 15,946 | -7,827 | -1,378 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 41.43 | -160.47 | 729.14 | -27.67 | 76.74 | 64.66 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | 0 | -0 |
Net Cash Flow | -2,065 | -4,384 | 3,947 | 5,419 | -5,473 | 231.21 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,065 | -552.04 | 3,783 | 3,112 | -301.51 | 2,557 |
Free Cash Flow Growth | -74.47% | - | 21.57% | - | - | -37.46% |
Free Cash Flow Margin | 3.53% | -1.79% | 11.93% | 10.44% | -1.09% | 8.79% |
Free Cash Flow Per Share | 40.65 | -21.39 | 146.44 | 128.72 | -12.76 | 118.08 |
Levered Free Cash Flow | 15.03 | -1,145 | 862.78 | 1,479 | -1,431 | -88.63 |
Unlevered Free Cash Flow | 66.48 | -1,089 | 1,010 | 1,621 | -1,111 | 311.06 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 88.46 | 92.33 | 243.22 | 257.88 | 250.5 | 362.28 |
Cash Income Tax Paid | - | -42.85 | -22.88 | - | -16.64 | 31.64 |
Change in Working Capital | -265.75 | -2,949 | -1,544 | -1,886 | -4,655 | -1,599 |